Diabetes insipidus and SIADH: Pathology review

14,880views

Diabetes insipidus and SIADH: Pathology review

Watch later

Watch later

Anatomical terminology
Introduction to the lymphatic system
Introduction to the muscular system
Introduction to the skeletal system
Metaplasia and dysplasia
Autosomal trisomies: Pathology review
Down syndrome (Trisomy 21)
Inheritance patterns
DNA damage and repair
DNA replication
Selective permeability of the cell membrane
Free radicals and cellular injury
Colorectal polyps and cancer: Pathology review
Oral cancer
Testicular cancer
Testicular tumors: Pathology review
Breast cancer
Prostate cancer
Lung cancer
Hypertension: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Arterial disease
Aortic valve disease
Asthma
Atrial septal defect
Bronchiectasis
Chronic bronchitis
Chronic venous insufficiency
Emphysema
Stroke volume, ejection fraction, and cardiac output
Peripheral artery disease
Pleural effusion
Coarctation of the aorta
Deep vein thrombosis
Endocarditis
Gas exchange in the lungs, blood and tissues
Heart failure
Mitral valve disease
Myocardial infarction
Patent ductus arteriosus
Pericarditis and pericardial effusion
Pneumonia
Pulmonary edema
Restrictive lung diseases
Atrioventricular block
Heart blocks: Pathology review
Bundle branch block
Pulseless electrical activity
Atrial fibrillation
Atrial flutter
Atrioventricular nodal reentrant tachycardia (AVNRT)
Premature atrial contraction
Wolff-Parkinson-White syndrome
Supraventricular arrhythmias: Pathology review
Brugada syndrome
Long QT syndrome and Torsade de pointes
Premature ventricular contraction
Ventricular fibrillation
Ventricular tachycardia
Ventricular arrhythmias: Pathology review
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
Cardiomyopathies: Pathology review
Cardiac tumors
Ventricular septal defect
Acyanotic congenital heart defects: Pathology review
Hypoplastic left heart syndrome
Tetralogy of Fallot
Transposition of the great vessels
Persistent truncus arteriosus
Total anomalous pulmonary venous return
Cyanotic congenital heart defects: Pathology review
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Cor pulmonale
Heart failure: Pathology review
Endocarditis: Pathology review
Myocarditis
Rheumatic heart disease
Cardiac tamponade
Dressler syndrome
Pericardial disease: Pathology review
Cardiovascular changes during hemorrhage
Pulmonary valve disease
Tricuspid valve disease
Valvular heart disease: Pathology review
Aneurysms
Aortic dissection
Aortic dissections and aneurysms: Pathology review
Angina pectoris
Coronary steal syndrome
Stable angina
Prinzmetal angina
Unstable angina
Coronary artery disease: Pathology review
Abetalipoproteinemia
Familial hypercholesterolemia
Hyperlipidemia
Hypertriglyceridemia
Atherosclerosis and arteriosclerosis: Pathology review
Dyslipidemias: Pathology review
Hypertension
Hypertensive emergency
Pheochromocytoma
Polycystic kidney disease
Renal artery stenosis
Hypotension
Orthostatic hypotension
Lymphangioma
Lymphedema
Shock
Shock: Pathology review
Subclavian steal syndrome
Peripheral artery disease: Pathology review
Behcet's disease
Kawasaki disease
Vasculitis
Vasculitis: Pathology review
Thrombophlebitis
Angiosarcomas
Human herpesvirus 8 (Kaposi sarcoma)
Vascular tumors
Cardiac and vascular tumors: Pathology review
Dementia: Pathology review
Anxiety disorders: Clinical
Arteriovenous malformation
Bipolar and related disorders
Cauda equina syndrome
Cranial nerves
Seizures and epilepsy
Generalized anxiety disorder
Headaches: Pathology review
Huntington disease
Ischemic stroke
Meningitis
Migraine
Myasthenia gravis
Panic disorder
Parkinson disease
Stroke: Clinical
Alzheimer disease
Adrenal cortical carcinoma
Adrenal masses: Pathology review
Adrenoleukodystrophy (NORD)
Congenital adrenal hyperplasia
Conn syndrome
Cushing syndrome
Cushing syndrome and Cushing disease: Pathology review
Hyperaldosteronism
Primary adrenal insufficiency
Adrenal insufficiency: Pathology review
Waterhouse-Friderichsen syndrome
McCune-Albright syndrome
5-alpha-reductase deficiency
Androgen insensitivity syndrome
Delayed puberty
Kallmann syndrome
Polycystic ovary syndrome
Precocious puberty
Premature ovarian failure
Alkaptonuria
Amyloidosis
Cystinosis
Cystinuria (NORD)
Disorders of amino acid metabolism: Pathology review
Disorders of carbohydrate metabolism: Pathology review
Disorders of fatty acid metabolism: Pathology review
Essential fructosuria
Fabry disease (NORD)
Galactosemia
Gaucher disease (NORD)
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glycogen storage disease type III
Glycogen storage disease type IV
Glycogen storage disease type V
Glycogen storage disorders: Pathology review
Hartnup disease
Hereditary fructose intolerance
Homocystinuria
Krabbe disease
Lactose intolerance
Lesch-Nyhan syndrome
Lysosomal storage disorders: Pathology review
Maple syrup urine disease
Metachromatic leukodystrophy (NORD)
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Niemann-Pick disease type C
Niemann-Pick disease types A and B (NORD)
Ornithine transcarbamylase deficiency
Orotic aciduria
Phenylketonuria (NORD)
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Pyruvate dehydrogenase deficiency
Tay-Sachs disease (NORD)
Multiple endocrine neoplasia
Multiple endocrine neoplasia: Pathology review
Neuroblastoma
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Opsoclonus myoclonus syndrome (NORD)
Pancreatic neuroendocrine neoplasms
Pituitary tumors: Pathology review
Zollinger-Ellison syndrome
Hyperparathyroidism
Hypoparathyroidism
Hypercalcemia
Hypocalcemia
Parathyroid disorders and calcium imbalance: Pathology review
Diabetes mellitus
Diabetes mellitus: Pathology review
Diabetic nephropathy
Diabetic retinopathy
Hyperpituitarism
Pituitary adenoma
Hyperprolactinemia
Prolactinoma
Acromegaly
Gigantism
Hypopituitarism
Hypopituitarism: Pathology review
Hypoprolactinemia
Pituitary apoplexy
Sheehan syndrome
Constitutional growth delay
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Diabetes insipidus and SIADH: Pathology review
Autoimmune polyglandular syndrome type 1 (NORD)
Thyroglossal duct cyst
Hyperthyroidism
Hyperthyroidism: Pathology review
Graves disease
Thyroid eye disease (NORD)
Toxic multinodular goiter
Thyroid storm
Hypothyroidism
Hypothyroidism: Pathology review
Euthyroid sick syndrome
Hashimoto thyroiditis
Subacute granulomatous thyroiditis
Riedel thyroiditis
Thyroid cancer
Thyroid nodules and thyroid cancer: Pathology review
Acute radiation syndrome
Fanconi anemia
Diamond-Blackfan anemia
Autoimmune hemolytic anemia
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Hemolytic disease of the newborn
Hereditary spherocytosis
Paroxysmal nocturnal hemoglobinuria
Pyruvate kinase deficiency
Sickle cell disease (NORD)
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Folate (Vitamin B9) deficiency
Megaloblastic anemia
Vitamin B12 deficiency
Alpha-thalassemia
Anemia of chronic disease
Beta-thalassemia
Iron deficiency anemia
Lead poisoning
Sideroblastic anemia
Microcytic anemia: Pathology review
Aplastic anemia
Non-hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Hemophilia
Vitamin K deficiency
Langerhans cell histiocytosis
Mastocytosis (NORD)
Myelodysplastic syndromes
Essential thrombocythemia (NORD)
Myelofibrosis (NORD)
Polycythemia vera (NORD)
Myeloproliferative disorders: Pathology review
Acute intermittent porphyria
Porphyria cutanea tarda
Heme synthesis disorders: Pathology review
Acute leukemia
Chronic leukemia
Leukemias: Pathology review
Leukemoid reaction
Hodgkin lymphoma
Non-Hodgkin lymphoma
Lymphomas: Pathology review
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Von Willebrand disease
Mixed platelet and coagulation disorders: Pathology review
Coagulation disorders: Pathology review
Bernard-Soulier syndrome
Glanzmann's thrombasthenia
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Platelet disorders: Pathology review
Antiphospholipid syndrome
Antithrombin III deficiency
Factor V Leiden
Protein C deficiency
Protein S deficiency
Thrombosis syndromes (hypercoagulability): Pathology review
Multiple myeloma
Monoclonal gammopathy of undetermined significance
Waldenstrom macroglobulinemia
Plasma cell disorders: Pathology review
Inflammation
Role of Vitamin K in coagulation
Androgens and antiandrogens
Aromatase inhibitors
Drug administration and dosing regimens
Enzyme function
Fat-soluble vitamin deficiency and toxicity: Pathology review

Transcript

Watch video only

Okay, so two people were admitted to the Endocrinology ward. One of them is 35 year old Imre, who came in with intense polyuria and polydipsia. Imre was dehydrated and presented with dry mouth, headache, dry skin and dizziness. Several tests were done and results showed increased serum osmolality and further on, a desmopressin test was done. During the test, an ADH analogue was administered and urine osmolality increased. The other person is 45 year old Sienna who came in to do some routine tests because she started taking cyclophosphamide and wanted to make sure that there are no complications. Her lab results showed hyponatremia, decreased blood osmolality, and her urine osmolality was higher than serum osmolality.

Now, both individuals are unable to maintain normal osmolality. But to understand this we need to go over a bit of physiology first. In the brain, specifically in the hypothalamus, there are osmoreceptors which can sense the osmolality of the blood, or how concentrated it is. Osmolality is the concentration of dissolved particles in the blood plasma, or the liquid portion of blood. There are a number of dissolved particles in the blood plasma, but the major ones are glucose, sodium, and blood urea nitrogen, and a normal osmolality is between 285 and 295 milliOsmoles per kilogram.

Now, during periods of dehydration there is an increase in concentration of these particles in the blood and osmolality increases. The osmoreceptors in the hypothalamus sense the change in osmolality and this triggers the sensation of thirst. The water that we drink gets absorbed and dilutes the blood, bringing the osmolality back to normal.

In addition to osmoreceptors, the hypothalamus also contains the supraoptic and paraventricular nuclei that produce antidiuretic hormone, or ADH, which is then sent to the posterior pituitary for storage. ADH is also called vasopressin because it causes smooth muscle around the blood vessels to contract, which increases resistance and raises blood pressure.

When the osmoreceptors detect high osmolality, they signal the supraoptic nucleus to send ADH into the blood which travels to the kidneys, specifically to the principal cells in the distal convoluted tubule, and collecting ducts, of the nephrons. Here ADH binds to a receptor called vasopressin receptor 2, or VR2. This causes aquaporin proteins inside the principal cells to embed into the cell membrane and open a channel that only lets water from the lumen of the nephron back into the blood. Just like drinking more water, this dilutes the blood, and returns plasma osmolality to a normal level. However, this reabsorption process also decides how much water leaves the body as urine, and how concentrated the urine is, which is one of the things that keeps a normal urine osmolality between 300 and 900 milliOsmoles per kilogram.

Now that we know all this, diabetes insipidus is when the kidneys reabsorb too little water, so the water remains in the nephrons and is lost via urine. This leads to a lot of dilute urine, or polyuria. Since there’s less water in the blood, plasma osmolality increases and that triggers thirst and polydipsia. Now, if the problem is caused by a lack of ADH, it’s called central diabetes insipidus. If it’s due to a decreased response to ADH by the kidneys, it’s called nephrogenic diabetes.

Let’s start with central diabetes insipidus, which can be caused by conditions that affect the hypothalamus, in which case it won’t be able to produce ADH, or conditions that affect the pituitary gland, in which case there’s no place to store the ADH, and in some cases, both the hypothalamus and the pituitary gland are affected. As a result, there’s insufficient ADH in the blood, and that means there is less vasoconstriction, and insufficient aquaporins in the distal convoluted tubule and collecting duct. Some causes of central diabetes insipidus include pituitary tumors, head trauma, head surgery, ischemic encephalopathy, autoimmune conditions or sometimes, the cause can be idiopathic.

Then there’s nephrogenic diabetes insipidus, which is when there’s a problem with the kidneys themselves, which makes them unresponsive to ADH. A high yield fact is that this is often due to a hereditary genetic defect of the vasopressin receptors or aquaporin proteins. Both of these lead to nephrons that are unresponsive to ADH. In addition, there are medications like lithium that can decrease the production of aquaporin proteins in the collecting duct. Sometimes, nephrogenic diabetes insipidus can be caused by hypokalemia. That’s because the aquaporins can degrade in the early phases of hypokalemia. Sometimes nephrogenic diabetes can also be secondary to hypercalcemia, through an unclear mechanism. Finally, demeclocycline, which is an ADH antagonist, can block the vasopressin receptors, leading to nephrogenic diabetes insipidus.

Now, the symptoms of both central and nephrogenic diabetes insipidus are polyuria and polydipsia and you have to remember this for your tests. A person with diabetes insipidus typically produces over 3 liters of dilute urine each day, so it can quickly lead to dehydration and hypotension. The increase in plasma osmolality can result in fatigue, nausea, poor concentration, or confusion.

The diagnosis of diabetes insipidus starts with a blood osmolality test, which would show an increased blood osmolality of above 290 milliosmoles per kilogram in both central and nephrogenic diabetes insipidus. The urine specific gravity is lower than 1006, meaning the kidneys aren’t able to properly concentrate urine. There’s also hyperosmotic volume contraction This means that there’s decreased extracellular fluid in the body, and the remaining fluid is hyperosmotic since the water is lost, but the solutes remain. Okay, the way to differentiate central and nephrogenic diabetes insipidus is to look at the ADH level; with central diabetes insipidus, there’s low ADH, while with nephrogenic diabetes insipidus, ADH is normal or high. Remember this as it’s a very high yield concept.

In addition, a water deprivation test can be done to distinguish diabetes insipidus from psychogenic polydipsia, which is when an individual drinks more water than they need, because of a variety of psychological or psychiatric causes. That’s where an individual doesn’t drink water for 2 to 3 hours, then hourly measurements of urine volume and osmolality are done. In a person with diabetes insipidus, urine osmolality will normally stay below 300 mOsm/kg despite having no fluid intake. With psychogenic polydipsia, urine osmolality increases during the test.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "undefined" Reviews in Endocrine and Metabolic Disorders (2003)
  4. "Treatment of Lithium-Induced Diabetes Insipidus with Amiloride" Pharmacotherapy (2003)
  5. "Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment" Mayo Clinic Proceedings (2010)
  6. "Syndrome of Inappropriate Antidiuretic Hormone Secretion Induced by a Single Dose of Oral Cyclophosphamide" Annals of Pharmacotherapy (2012)